Robert M. Plenge

Insider Reports History

Entity
Individual
Location
C/O Translate Bio, Inc., 29 Hartwell Avenue, Lexington, MA
Signature
/s/ Lisa A. Atkins, attorney-in-fact for Robert M. Plenge
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert M. Plenge:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BRISTOL MYERS SQUIBB CO EVP, Chief Research Officer Market Share Units 15.5K $833K $53.79 Mar 10, 2024 Direct
BRISTOL MYERS SQUIBB CO EVP, Chief Research Officer Common Stock, $0.10 par value 11.3K $609K $53.79 Mar 10, 2024 Direct
BRISTOL MYERS SQUIBB CO EVP, Chief Research Officer Common Stock, $0.10 par value 1.66K $89.1K $53.79 Mar 10, 2024 BMS Savings and Investment Program
BRISTOL MYERS SQUIBB CO EVP, Chief Research Officer Common Stock, $0.10 par value 200 $10.8K $53.79 Mar 10, 2024 Family Trust
BRISTOL MYERS SQUIBB CO EVP, Chief Research Officer Performance Shares 23.2K Mar 10, 2024 Direct
BRISTOL MYERS SQUIBB CO EVP, Chief Research Officer Restricted Stock Units 0 $50.10 Dec 2, 2023 Direct
Translate Bio, Inc. Director Stock Option (right to buy) 0 Sep 14, 2021 Direct

Insider Reports Filed by Robert M. Plenge

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMY BRISTOL MYERS SQUIBB CO Mar 10, 2024 16 -$106K 4 Mar 12, 2024 EVP, Chief Research Officer
BMY BRISTOL MYERS SQUIBB CO Dec 2, 2023 3 -$13.7K 4 Dec 5, 2023 EVP, Chief Research Officer
BMY BRISTOL MYERS SQUIBB CO Aug 3, 2023 1 -$44.8K 4 Aug 7, 2023 EVP, Chief Research Officer
BMY BRISTOL MYERS SQUIBB CO Jul 3, 2023 0 $0 3 Jul 5, 2023 EVP, Chief Research Officer
TBIO Translate Bio, Inc. Sep 14, 2021 4 $0 4 Sep 14, 2021 Director
TBIO Translate Bio, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director